GLP-1 Weight-Loss Meds Won't Raise Teens' Suicide Risk, May Even Lower It
MONDAY, Oct. 14, 2024 (HealthDay News) -- As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the risk for suicide and suicidal thoughts.
Three cities in Hawaii, Minnesota, and Texas report the highest usage of injectable weight loss medications. Meanwhile, ...
WEDNESDAY, Oct. 9, 2024 (HealthDay News) -- When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and ...
Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
New Scientist on MSN4d
Weight-loss drugs lower impulse to eat – and perhaps to exercise tooPopular weight-loss medications including Ozempic and Wegovy contain a drug that seems to decrease cravings for food and ...
One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...
A growing number of employers are considering covering the blockbuster weight-loss drugs, several surveys show. Workers will ...
They’re due for a jab of justice. New Yorkers are brazenly reselling prescription diabetic and weight loss medications online through Facebook Marketplace — despite risking up to 15 years in ...
A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs ...
In addition to availability, the cost of weight loss drugs like Wegovy and Zepbound is a major barrier preventing many ...
14hon MSN
Just 800 of the 13,500 patients eligible to start receiving Wegovy, which can help obese people lose 15% of their body weight ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback